Jiangsu Boquan Biotechnology

Jiangsu Boquan Biotechnology is a medical technology company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and automated instruments. Based in the China Medical City in Taizhou, the company focuses on point-of-care testing (POCT) solutions, utilizing advanced technologies such as time-resolved fluorescence immunoassay (TRFIA) and colloidal gold immunochromatography. Their commercial portfolio includes a wide range of rapid diagnostic kits for cardiovascular markers, inflammatory indicators, infectious diseases, and chronic disease management. Boquan Biotechnology operates GMP-compliant production facilities and holds ISO13485 certification to ensure high-quality standards for clinical laboratories and emergency departments. The company aims to provide efficient, accurate, and user-friendly diagnostic tools to improve patient outcomes in primary and acute care settings.